Skip to content
CancerIndex

Publication

Independent prognostic value of semaphorin-4D, interleukin-1β and complement activation in newly diagnosed multiple myeloma patients.

Ioannis Ntanasis-Stathopoulos, Panagiota-Efstathia Nikolaou, Charalampos Filippatos, Marios Miliotis, Ioannis V Kostopoulos, Panagiotis Bakouros, Manousos Makridakis, Christine-Ivy Liacos, Konstantinos Nikolopoulos, Stamatia Laidou, Anastasia Chatzidimitriou, Maria Frantzi, Efstathios Kastritis, Despina Fotiou, Maria Gavriatopoulou, Antonia Vlahou, Artemis G Hatzigeorgiou, Ourania Tsitsilonis, Meletios Athanasios Dimopoulos, Evangelos Terpos

HaematologicaSep 3, 2026PMID 42687818doi:10.3324/haematol.2026.301208 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260908-000002
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Multiple myeloma represents a systemic disease of the bone marrow (BM) niche, in which immune and skeletal pathways are tightly interconnected. However, the independent prognostic significance of bone and immune-related markers in newly diagnosed multiple myeloma (NDMM) remains incompletely…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.